Evidence map›Paper›PMID 27211891›Full record

ArticleOrganic & biomolecular chemistry2016

Synthesis of tumor necrosis factor α for use as a mirror-image phage display target.

Mark E Petersen, Michael T Jacobsen, Michael S Kay

Open access · greenAbstract read
In one paragraph

Article in Organic & biomolecular chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Loquacious-PD facilitatesProceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Mark E PetersenDepartment of Biochemistry, University of Utah, 15 N Medical Drive East, Rm 4100, Salt Lake City, Utah 84112-5650, USA. Kay@biochem.utah.edu.
Michael T Jacobsen
Michael S Kay
University of Utah · USSalt Lake Regional Medical Center · US

Funding

TRAINING IN CARDIOVASCULAR RESEARCHT32HL007576 · NHLBI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Stavros George Drakos, Robin M Shaw · 1985 to 2026
$10.6M
D-peptide Inhibitors of HIV-1 EntryR01AI076168 · NIAID · UNIVERSITY OF UTAH · PI KAY, MICHAEL S · 2008 to 2017
$3.1M
Characterization and Development of a Coiled-Coil to Treat Non-Hodgkin LymphomaF31CA171677 · NCI · UNIVERSITY OF UTAH · PI JACOBSEN, MICHAEL · 2012 to 2013
$84k
NCI NIH HHS F31 CA171677NHLBI NIH HHS T32 HL007576NIAID NIH HHS R01 AI076168
6 · The paper itself

Abstract

Tumor Necrosis Factor alpha (TNFα) is an inflammatory cytokine that plays a central role in the pathogenesis of chronic inflammatory disease. Here we describe the chemical synthesis of l-TNFα along with the mirror-image d-protein for use as a phage display target. The synthetic strategy utilized native chemical ligation and desulfurization to unite three peptide segments, followed by oxidative folding to assemble the 52 kDa homotrimeric protein. This synthesis represents the foundational step for discovering an inhibitory d-peptide with the potential to improve current anti-TNFα therapeutic strategies.

Indexed as

Peptide LibraryModels, MolecularProtein Structure, SecondaryStereoisomerismTumor Necrosis Factor-alphaPeptide LibraryTumor Necrosis Factor-alpha

Identifiers

PMID27211891
PMCPMC4900166
OpenAlexW2387227318

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.